Skip to content
10-Q

Quarterly Report

VIROPHARMA INC

0001104659-13-058946

← back to feed
Filed
Aug 1, 2013 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2013 · Jul 22, 2013 65.52M sh
Shares Diluted Q2 2013 · Jun 30, 2013 68.92M sh
Shares Diluted Q2 2013 · Jun 30, 2013 65.28M sh
Shares Diluted Q2 2013 · Jun 30, 2012 69.39M sh
Shares Diluted Q2 2013 · Jun 30, 2012 73.03M sh
Capex Q2 2013 · Jun 30, 2013 $1.19M
Capex Q2 2013 · Jun 30, 2012 $585K
Cash And Equivalents Q2 2013 · Jun 30, 2013 $191.4M
Cash And Equivalents Q2 2013 · Dec 31, 2012 $175.52M
Cash And Equivalents Q2 2013 · Jun 30, 2012 $357.21M
Cash And Equivalents Q2 2013 · Dec 31, 2011 $331.35M
Stockholders Equity Q2 2013 · Jun 30, 2013 $709.78M
Stockholders Equity Q2 2013 · Dec 31, 2012 $757.04M
Current Liabilities Q2 2013 · Jun 30, 2013 $89.76M
Current Liabilities Q2 2013 · Dec 31, 2012 $114.03M
Total Liabilities Q2 2013 · Jun 30, 2013 $403.33M
Total Liabilities Q2 2013 · Dec 31, 2012 $462.91M
Current Assets Q2 2013 · Jun 30, 2013 $468.53M
Current Assets Q2 2013 · Dec 31, 2012 $453.42M
Total Assets Q2 2013 · Jun 30, 2013 $1.11B
Total Assets Q2 2013 · Dec 31, 2012 $1.22B
Eps Diluted Q2 2013 · Jun 30, 2013 $0.01
Eps Diluted Q2 2013 · Jun 30, 2013 −$0.97
Eps Diluted restated Q2 2013 · Jun 30, 2012 −$0.08
Eps Diluted restated Q2 2013 · Jun 30, 2012 $0.19
Eps Basic Q2 2013 · Jun 30, 2013 $0.01
Eps Basic Q2 2013 · Jun 30, 2013 −$0.97
Eps Basic restated Q2 2013 · Jun 30, 2012 −$0.08
Eps Basic restated Q2 2013 · Jun 30, 2012 $0.20
Sga Expense Q2 2013 · Jun 30, 2013 $46.24M
Sga Expense Q2 2013 · Jun 30, 2013 $88.96M
Sga Expense Q2 2013 · Jun 30, 2012 $40.88M
Sga Expense Q2 2013 · Jun 30, 2012 $79.05M
Rd Expense Q2 2013 · Jun 30, 2013 $17.17M
Rd Expense Q2 2013 · Jun 30, 2013 $34.36M
Rd Expense Q2 2013 · Jun 30, 2012 $16.62M
Rd Expense Q2 2013 · Jun 30, 2012 $32.02M
Operating Income Q2 2013 · Jun 30, 2013 $3.79M
Operating Income Q2 2013 · Jun 30, 2013 −$94.07M
Operating Income restated Q2 2013 · Jun 30, 2012 −$599K
Operating Income restated Q2 2013 · Jun 30, 2012 $39.54M
Cost Of Revenue Q2 2013 · Jun 30, 2013 $28.16M
Cost Of Revenue Q2 2013 · Jun 30, 2013 $58.02M
Cost Of Revenue restated Q2 2013 · Jun 30, 2012 $28.09M
Cost Of Revenue restated Q2 2013 · Jun 30, 2012 $60.17M
Stock Repurchased Q2 2013 · Jun 30, 2012 $71.52M